Clinical Trials Browser

Withdrawn × Head & Neck × 1 year × Clear all

NCT01451853 2026-06-03

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Phase 2 Withdrawn

Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

NCT05363709 2026-05-12

BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients

Phase 2 Withdrawn

Oropharyngeal Neoplasms

NCT01536782 2026-04-29

Optimal Tube Feeding Method in Head and Neck Cancer Patients

Phase NA Withdrawn

Head and Neck Neoplasms

NCT03953352 2026-04-15

GIRAFE

Phase NA Withdrawn

Head and Neck Neoplasms

NCT05296135 2026-02-27

PREDAPT-HNSCC2

Squamous Cell Carcinoma of Head and Neck

NCT06098755 2026-02-04

The Sequestration of Holistic Stress Management Techniques for Adults

Phase NA Withdrawn

Classical hematologyHead & NeckOther

Brain Injuries, Traumatic, Occupational Stress, Anemia, Anemia, Sickle Cell, Anxiety Disorders, Arthritis, Arthritis, Rheumatoid, Depression, Escape Reaction, Fatigue, Flatfoot, Hemorrhoids, Hypertension, Hyperthyroidism, Immunologic Deficiency Syndromes, Erectile Dysfunction, Leiomyoma, Lordosis, Masturbation, Migraine Disorders, Priapism, Sickle Cell Trait, Stress Disorders, Post-Traumatic, Sexual Dysfunctions, Psychological, Migraine with Aura

NCT05850663 2026-02-03

Quality of Life Assessment of Radiotherapy in Recurrent Head and Neck Cancer

Phase NA Withdrawn

GynecologicHead & Neck

Uterine Cervical Neoplasms, Head and Neck Neoplasms, Endometrial Neoplasms

NCT06603155 2025-12-19

Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)

Phase NA Withdrawn

GenitourinaryHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell

NCT05668949 2025-12-17

Phase I/II Open Label Study Evaluating the Safety and Efficacy of Combining STAT3 Inhibition (TTI-101) With Anti-PD-1 Therapy (Pembrolizumab) in Patients With Recurrent or Metastatic (RM) Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 1/2 Withdrawn

Squamous Cell Carcinoma of Head and Neck

NCT05845307 2025-12-08

Randomized Pre-surgical Window-of-Opportunity Trial of TTI-101 in Patients With Stage II-IV Resectable HPV-negative Squamous Cell Carcinoma of the Head and Neck

Phase EARLY_PHASE1 Withdrawn

Squamous Cell Carcinoma of Head and Neck

NCT04741256 2025-12-02

Implementation of a Standardized Tracheostomy Education Discharge Protocol

Phase NA Withdrawn

Head and Neck Neoplasms

NCT06804850 2025-11-19

Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC

Phase 2 Withdrawn

Head and Neck Neoplasms

NCT05954676 2025-10-28

Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery

Phase NA Withdrawn

Head and Neck Neoplasms

NCT05774535 2025-10-02

TIROVASC

Euthyroid Goiter, Cardiovascular Diseases, Graves Disease, Hyperthyroidism, Thyroid Diseases, Thyroid Neoplasms

NCT05754216 2025-10-01

Intraoperative Identification and Stimulation of the Glossopharyngeal Nerve

Phase NA Withdrawn

Head and Neck Neoplasms, Sleep Apnea, Obstructive

NCT05108233 2025-09-29

Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course

Head and Neck Neoplasms

NCT01326468 2025-09-25

Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

Phase NA Withdrawn

Head and Neck Neoplasms

NCT06276946 2025-09-05

Sparing Parotid Ducts Via MRI Sialography for Reduced Patient Reported Xerostomia

Phase NA Withdrawn

Head and Neck Neoplasms, Oropharyngeal Neoplasms, Xerostomia

NCT04053114 2025-08-29

MOLTHYSO

GynecologicHead & Neck

Teratoma, Ovarian, Ovarian Neoplasms, Struma Ovarii, Thyroid Neoplasms

NCT06362421 2025-07-31

Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

NCT06347185 2025-07-17

SupCare

Phase NA Withdrawn

Head and Neck Neoplasms

NCT06086925 2025-07-11

A Window of Opportunity Study of Black Raspberry for Patients With HNSCC

Phase EARLY_PHASE1 Withdrawn

Squamous Cell Carcinoma of Head and Neck

NCT05879484 2025-07-10

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Phase 1/2 Withdrawn

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lung Neoplasms

NCT06513884 2025-06-22

A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

Phase 2/3 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell